SMT, PCB Electronic Industry News

News Releases from PerkinElmer Optoelectronics

Read PerkinElmer Optoelectronics company news


50 news releases added by PerkinElmer Optoelectronics

Company Information:

PerkinElmer Optoelectronics

Manufacturer of Specialty Lighting and Medical Measurement Equipment

Salem, Massachusetts, USA

Manufacturer

  • Phone 978-224-4100
  • Fax 978-741-3947

PerkinElmer Optoelectronics website

Company Postings:

(50) news releases

PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.

Feb 06, 2009 | WALTHAM, Mass., Feb 03, 2009 (BUSINESS WIRE) PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, announced the acquisition of Opto Technology, Inc., a leading supplier of light-emitting diode (LED) based lighting components and subsystems.

PerkinElmer Announces Financial Results for the Fourth Quarter of 2008

Jan 30, 2009 | PerkinElmer, Inc. (NYSE: PKI - News), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the fourth quarter ended December 28, 2008. The Company reported GAAP earnings per share from continuing operations of $0.29. On a non-GAAP basis, which includes the adjustments noted in the attached reconciliation, the Company announced adjusted earnings per share of $0.48, which is within the range of the Company's prior guidance.

PerkinElmer Launches Volocity 5� High Performance Imaging Acquisition and Analysis Software

Nov 18, 2008 | Washington, D.C. - PerkinElmer, Inc., a global leader in life science research, drug discovery and cellular science, today announced the launch of the Volocity� 5 high performance imaging software suite, developed by Improvision, a PerkinElmer company, at the Society for Neuroscience conference.

PerkinElmer Launches Online Radiochemical Tool Kit To Support Customers' Critical Laboratory Requirements

Sep 16, 2008 | WALTHAM � PerkinElmer, a global leader in life science research, drug discovery and cellular science, today announced the launch of its online radiochemical tool kit, a comprehensive suite of interactive, Web-based applications designed to provide researchers with hands-on access to information they need to support their critical lab requirements. The new online radiochemical tool kit helps customers perform key lab calculations, assists with lab equipment and reagent management, and provides new and more efficient methods for locating key product and technical information.

PerkinElmer to Present at UBS Global Life Sciences Conference

Sep 16, 2008 | WALTHAM, Mass.(BUSINESS WIRE)Sept. 16, 2008PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008, at 12:30 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.

PerkinElmer to Triple Neonatal Screening Capacity in Mexico

Jul 24, 2008 | WALTHAM, Mass.(BUSINESS WIRE)July 21, 2008PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced a one-year agreement with the Mexican Ministry of Health, la Secretaria de Salud, to expand its newborn screening program across Mexico. Under the terms of the agreement, PerkinElmer will provide instrumentation, reagents and screening expertise that will help the Ministry of Health screen for congenital hypothyroidism and triple its screening capacity. The expanded program began in May 2008.

Dr. Alan Fletcher Joins PerkinElmer as Vice President of Bio-Discovery Business Development

Jul 14, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--July 14, 2008--PerkinElmer, Inc. (NYSE: PKI), a leader in Health Sciences and Photonics, today announced that Alan Fletcher, Ph.D., has joined the Company as vice president, business development for PerkinElmer's Life and Analytical Sciences business. In this role, Fletcher will be responsible for growing the Bio-discovery business through the development of strategic partnerships and alliances in the life science research area, and the introduction of new technologies for GPCR, kinase and biomarker drug target classes.

PerkinElmer Appoints Its Chief Scientific Officer Daniel Marshak to Lead Greater China Operations

Jul 08, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--July 7, 2008--PerkinElmer, Inc. (NYSE: PKI), today announced the appointment of Daniel R. Marshak, Ph.D., to the additional position of president of its Greater China operations. In this role, Marshak will assume overall leadership of PerkinElmer in Greater China, and will be responsible for expanding its resources in the region to drive innovation and new product introductions. He will be based out of Shanghai, strengthening the Company's executive and scientific presence in the country. Marshak will continue in his role as senior vice president and chief scientific officer for the Company.

PerkinElmer Unveils Tailored LIMS Solutions for Water, Food and Petrochemical Laboratory Customers

Jul 01, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--June 30, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced three market-specific LABWORKS(TM) Laboratory Information Management Systems (LIMS) packages that address increasing regulatory and compliance pressures. The new packages are aimed at addressing the critical data management needs of customers in water, food and petrochemical laboratories.

PerkinElmer Receives 2008 Life Science Industry Award for Achievement in High Throughput Screening

Jun 16, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--June 12, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it has received top honors in the Life Science Industry Awards for High Throughput Screening (HTS) and Analysis Systems. For the second consecutive year, the Company was named a winner in the Life Science Industry Awards, which are determined based on the input of nearly 4,500 scientists worldwide, and recognize life science companies offering best-in-class technology and service over the past year.

PerkinElmer Announces Michael Battles to Become Interim CFO

May 23, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--May 19, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that Michael L. Battles, the Company's vice president and controller, will lead the finance function on an interim basis, reporting directly to president and chief executive officer, Robert F. Friel. PerkinElmer's current chief financial officer, Jeffrey D. Capello, is resigning to pursue another opportunity outside the Company effective June 6, 2008.

PerkinElmer Expands EcoAnalytix(TM) Initiative to India, Strengthens Global Application Development

May 18, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--May 15, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the expansion of its health and environmental focus to India with the opening of a new global EcoAnalytix(TM) application and technical center in Mumbai. The EcoAnalytix application and technical center will be dedicated to application development and methods optimization for a range of scientific and industrial laboratory applications, including environmental monitoring, food safety, and sustainable energy.

PerkinElmer to Present at May Healthcare Conferences

May 01, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--April 30, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today announced that it will present at four upcoming financial conferences.

PerkinElmer Announces Financial Results for the First Quarter 2008

Apr 25, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--April 24, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today reported financial results for the first quarter ended March 30, 2008. The Company reported GAAP earnings per share from continuing operations of $0.20. On a non-GAAP basis, which includes the adjustments noted in the attached reconciliation, the Company announced adjusted earnings per share of $0.29, which is above the Company's prior guidance of $0.26 to $0.27.

PerkinElmer First Quarter Earnings and Conference Call Notification

Apr 16, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--April 14, 2008--PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, April 24, 2008, after market close, the Company will release first quarter 2008 results.

PerkinElmer Partners with Cerep for Custom Drug Discovery Solutions

Apr 07, 2008 | Supply and Co-Marketing Agreement Provides Biotechnology and Pharmaceutical Customers with a Total Solution for Drug Candidate Detection and Validation

PerkinElmer Extends Its Leadership in Drug Candidate Detection Instrumentation

Apr 07, 2008 | ST. LOUIS--(BUSINESS WIRE)--April 7, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced the launch of its VICTOR(TM) X Multilabel Plate Reader platform at the Society for Biomolecular Sciences' (SBS) 14th Annual Conference and Exhibition. The new VICTOR X platform will deliver to customers increased flexibility, while its enhanced versatility will enable support of new applications beyond primary screening, including quality control and therapeutic research.

PerkinElmer Announces Global R&D Expansion in Singapore

Mar 26, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 26, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today celebrated the opening of a new Center of Excellence in Singapore. The PerkinElmer Inc. Center of Excellence in Singapore comes as part of PerkinElmer's continued global R&D expansion efforts, and will focus on the development of new precision instrumentation and chemistries for a range of scientific and industrial laboratory applications, including drug discovery and development, environmental monitoring, food safety, and sustainable energy.

PerkinElmer Appoints Dr. John Sherwin to Lead Genetic Screening Laboratory Services

Mar 24, 2008 | Distinguished Laboratory Director Joins Company to Drive Quality and Growth in Neonatal and Prenatal Service Business

PerkinElmer Has Announced Date for 2008 Annual Meeting of Shareholders

Mar 24, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 24, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, has announced that it will hold its Annual Meeting of Shareholders on Tuesday, April 22, 2008, at 10:30 a.m. ET at the Company's corporate offices, 940 Winter Street, Waltham, MA.

PerkinElmer to Present at Bank of America 2008 Small/Mid Cap Conference

Mar 20, 2008 | WALTHAM, Mass., Mar 20, 2008 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that it will present at the Bank of America 2008 Small/Mid Cap Conference on Wednesday, March 26, 2008, at 11:20 a.m. Eastern Time at the Four Seasons Hotel in Boston.

PerkinElmer to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference

Mar 15, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 10, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that it will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference on Tuesday, March 18, 2008, at 9:30 a.m. Eastern Time at the Loews Miami Beach Hotel in Miami, Florida.

PerkinElmer Achieves Milestone in Global Deployment of Specialized Information Management Solution for Genetic Screening Laboratories

Mar 15, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--March 13, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that Specimen Gate(R), its specialized information management solution for genetic screening laboratories, has been deployed across more than 70 countries, states and provinces worldwide. The Specimen Gate product portfolio is a critical element of both neonatal and prenatal screening programs, many of which are implemented at the state or national levels of countries around the world, resulting in the identification of thousands of infants at risk of genetic disease each year.

PerkinElmer Highlights EcoAnalytix(TM) Initiative and New Products at PITTCON(R) 2008

Mar 03, 2008 | NEW ORLEANS-March 3, 2008--PerkinElmer, Inc.(NYSE: PKI), a global leader in health sciences and photonics, today announced that it is showcasing its new EcoAnalytix(TM) initiative at PITTCON(R) 2008, March 2-6, 2008 Booth #2555. EcoAnalytix is PerkinElmer's revolutionary problem-solving initiative that addresses the global imperatives of food and consumer product safety, water quality and sustainable energy development.

PerkinElmer Completes Acquisition of Pediatrix's Newborn Metabolic Screening Business

Mar 01, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 29, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced that it has successfully completed its acquisition of the newborn metabolic screening business of Pediatrix Medical Group, Inc. (NYSE: PDX). The completion of this transaction expands PerkinElmer's capabilities in the neonatal health field.

PerkinElmer Elects Patrick J. Sullivan as Director

Feb 25, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 25, 2008--PerkinElmer, Inc. (NYSE:PKI), a global technology leader in Health Sciences, today announced that Patrick J. Sullivan, Executive Chairman of Hologic, Inc. (NASDAQ: HOLX), has been elected to the Company's Board of Directors.

PerkinElmer to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Feb 03, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 31, 2008--PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, 2008, at 4:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.

PerkinElmer Board Declares Quarterly Dividend

Jan 28, 2008 | WALTHAM, Mass.-Jan. 23, 2008--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), meeting on January 23, 2008, declared a regular quarterly dividend of $.07 per share of common stock. This dividend is payable on May 9, 2008, to all shareholders of record at the close of business on April 18, 2008.

PerkinElmer Announces Financial Results for the Fourth Quarter of 2007

Jan 28, 2008 | WALTHAM, Mass.--Jan. 24, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today reported financial results for the fourth quarter and fiscal year ended December 30, 2007. For the fourth quarter 2007, the Company reported GAAP earnings per share from continuing operations of $0.46.

PerkinElmer Elects Robert F. Friel as Chief Executive Officer

Jan 28, 2008 | WALTHAM, Mass.- Jan. 23, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that Robert F. Friel has been elected Chief Executive Officer by the Company's Board of Directors effective February 1, 2008. He will also retain the title of President.

PerkinElmer Introduces Wizard2 Automatic Gamma Counter With Advanced Ease-Of-Use Features

Jan 16, 2008 | WALTHAM, Mass. � PerkinElmer Life and Analytical Sciences, a global leader in life science research, drug discovery and cellular science, today announced the launch of the new WIZARD2� Automated Gamma Counter.

PerkinElmer Fourth Quarter Earnings and Conference Call Notification

Jan 16, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--Jan. 16, 2008--PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, January 24, 2008, after market close, the Company will release fourth quarter 2007 results.

PerkinElmer to Present at JPMorgan Healthcare Conference

Jan 04, 2008 | WALTHAM, Mass., Dec 31, 2007- PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that it will present at the JPMorgan Healthcare Conference on Tuesday, January 8, 2008, at 11:30 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco.

PerkinElmer to Expand Newborn Health Through Acquisition of Pediatrix's Metabolic Screening Laboratory

Dec 27, 2007 | WALTHAM, Mass.--(BUSINESS WIRE)--Dec. 19, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced the signing of a definitive agreement with Pediatrix Medical Group, Inc. (NYSE: PDX) under which PerkinElmer will acquire the newborn metabolic screening business of Pediatrix in a cash transaction.

PerkinElmer Announces Increased Market Adoption of Xenon Flash for Mobile Phone Cameras

Dec 13, 2007 | WALTHAM, Mass., Dec 12, 2007, PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced it has received additional production orders for mobile phone flash assemblies incorporating its Xenon-based flash technology.

PerkinElmer Completes Acquisition of ViaCell

Nov 15, 2007 | WALTHAM, Mass.--(BUSINESS WIRE)--Nov. 15, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced that it has successfully completed its acquisition of ViaCell, Inc., a biotechnology company specializing in the collection and preservation of umbilical cord blood stem cells.

PerkinElmer Announces Successful Completion of Cash Tender Offer for ViaCell

Nov 12, 2007 | WALTHAM & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 9, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences, today announced the successful completion of its tender offer to acquire all outstanding shares of common stock of ViaCell, Inc. (Nasdaq: VIAC), at a price of $7.25 per share, in cash.

PerkinElmer Launches Innovative Live Cell Imaging Solution

Nov 05, 2007 | New UltraVIEW(R) VoX System Integrates Confocal Microscopy and Software Technologies for High-Speed, High-Quality Cell Imaging and Analysis

PerkinElmer Charts Growth Strategy for Investors

Nov 04, 2007 | NEW YORK, Nov 02, 2007 (BUSINESS WIRE) -- PerkinElmer, Inc. (NYSE: PKI) today announced the availability of a webcast replay of its 2007 Analyst Meeting, held Friday, November 2, 2007, at the Millennium Broadway Hotel in New York City.

PerkinElmer Announces Expiration of Hart-Scott-Rodino Waiting Period of Proposed ViaCell Acquisition

Oct 26, 2007 | WALTHAM, Mass. & CAMBRIDGE, Mass.-Oct. 25, 2007-PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, today announced that the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, as amended, expired on October 24, 2007, with respect to its tender offer for ViaCell, Inc. (Nasdaq: VIAC).

PerkinElmer Announces Financial Results for the Third Quarter of 2007

Oct 26, 2007 | WALTHAM, Mass.-Oct. 25, 2007-PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today reported financial results for the third quarter and nine months ended September 30, 2007. For the third quarter 2007, the Company reported GAAP earnings per share from continuing operations of $0.26.

PerkinElmer Announces Global Launch of EcoAnalytix(TM) Initiative

Oct 18, 2007 | BEIJING-Oct. 17, 2007-PerkinElmer, Inc. (NYSE: PKI) a global technology leader in Health Sciences, today unveiled EcoAnalytix(TM), a revolutionary problem-solving initiative that addresses the global imperatives of food safety, water quality and biofuels development.

PerkinElmer Commences Cash Tender Offer for ViaCell

Oct 12, 2007 | WALTHAM & CAMBRIDGE, Mass.-Oct. 12, 2007-On October 12, 2007, Victor Acquisition Corp., an indirect wholly owned subsidiary of PerkinElmer, Inc. (NYSE: PKI), commenced a tender offer to acquire all outstanding shares of common stock of ViaCell, Inc. (Nasdaq: VIAC), at a price of $7.25 per share, in cash, pursuant to a previously announced Agreement and Plan of Merger among PerkinElmer, Inc., Victor Acquisition Corp. and ViaCell, Inc., dated October 1, 2007.

PerkinElmer Responds to Food Contamination Crisis with Innovative Melamine Analyzer

Oct 11, 2007 | WALTHAM, Mass.-Oct. 11, 2007-PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, today announced a complete analytical solution for the determination of melamine adulteration in protein-based foods. With the release of the Melamine Analyzer, based on the innovative Clarus(R) 600 T Gas Chromatograph/Mass Spectrometer (GC/MS), PerkinElmer is the first in the industry to provide such solution using GC/MS technology.

PerkinElmer Introduces Enhanced Protein Analysis and Imaging Portfolio

Oct 09, 2007 | SEOUL, South Korea--(BUSINESS WIRE)--Oct. 8, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, dramatically strengthens its portfolio of protein analysis and imaging technologies with the introduction of five new products at the Human Proteome Organization's (HUPO) 6th Annual World Congress in Seoul, South Korea, Oct. 6-10.

PerkinElmer Third Quarter Earnings and Conference Call Notification

Oct 05, 2007 | WALTHAM, Mass-Oct. 5, 2007-PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, October 25, 2007, after market close, the Company will release third quarter 2007 results.

PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell

Oct 02, 2007 | WALTHAM, Mass. & CAMBRIDGE, Mass. -Oct. 1, 2007- PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, and ViaCell, Inc. (Nasdaq: VIAC), a biotechnology company specializing in the collection and preservation of umbilical cord blood stem cells, announced today the signing of a definitive agreement under which PerkinElmer plans to acquire ViaCell.

PerkinElmer Opens Expanded Digital X-Ray Detector Facility

Oct 01, 2007 | SANTA CLARA, Calif.-Sept. 28, 2007-PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the expansion of its Santa Clara, California, digital x-ray detector fabrication facility. The 80,000-square foot facility produces amorphous silicon digital x-ray detector panels for use in radiography, angiography, cardiovascular imaging, and radiation oncology.

PerkinElmer to Present at UBS 2007 Global Life Sciences Conference

Sep 18, 2007 | WALTHAM, Mass. -Sept. 18, 2007 - PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 24, 2007, at 4:00 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.

PerkinElmer to Host Analyst Meeting on Friday, November 2, 2007

Sep 13, 2007 | WALTHAM, Mass.-- Sept. 12, 2007--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics markets, announced that it will host an Analyst Meeting on Friday, November 2, 2007, starting at 9:00 a.m. Eastern Time at the Millennium Broadway Hotel in New York City.

Zero returns due to coating issues

Non-heated dispensing system